Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer

Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:14:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error in place of the study record for sacituzumab govitecan in adults with epithelial cancer.
    Difference
    22%
    Check dated 2026-10-04T16:05:27.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays a 403 error instead of the study record content, replacing the detailed study information and navigation with a generic error page.
    Difference
    22%
    Check dated 2026-09-20T19:53:35.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the previous v3.6.5 in the page footer. It indicates a minor platform update and does not change the study details on the page.
    Difference
    0.0%
    Check dated 2026-08-30T16:05:39.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    - A new publication citation was added to the Publications section: Sathe AG, Jones AK, Diderichsen PM, Wang X, Chang P, Verret W, Girish S. Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2- Metastatic Breast Cancer Data From the Phase 3 TROPiCS-02 Trial. Clin Transl Sci. 2025 Jul;18(7):e70291. doi: 10.1111/cts.70291. This entry expands the study's referenced literature by including a 2025 pharmacokinetics analysis of Sacituzumab Govitecan in HR+/HER2- metastatic breast cancer.
    Difference
    0.0%
    Check dated 2026-08-23T08:50:52.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor software update to the site. There is no change to the study content visible to users.
    Difference
    0.0%
    Check dated 2026-08-08T23:30:17.000Z thumbnail image

Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer

Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.